Clinical Trial Update: Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying nimotuzumab in combination with chemoradiotherapy for esophageal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer, Nimotuzumab | Phase 2 | Status: RECRUITING